Early studies describe upregulation of TGF-β in invasive HCC [24], low levels of TβRII in HCC with intrahepatic metastasis [25,26] and elevated levels of Smad7 in late stage HCC and other cancers [10,27,28]. Here, SMAD7 is linked to hepatocellular carcinoma.